BMD, European specialist in advanced diagnostics, is introducing a pilot scheme for remote medical testing at the cardiology unit of Arras Hospital.
Remote testing has long been sought after by emergency units in hospitals and has been implemented in Arras using BMD’s expertise in in-vitro diagnostics and software architecture. The system will improve the way in which urgent cases are treated in the emergency room and will enable physicians to make vital cardiological diagnoses with increased accuracy.
Using the new system, clinicians carry out tests at the point-of-care and send test results over the internet to be analyzed in the laboratory. Once checked out by the lab, the lab then immediately sends its results back to the clinicians. Typical total turnaround time is around fifteen minutes. The system rapidly identifies signs of a heart attack or heart failure, thus considerably reducing the risk of death.
The technology ensures that information gained from the tests is added to the patient¹s medical file and so remains easily accessible for the duration the patient¹s stay in hospital. BMD selected the Triage Meter System, developed by BIOSITE and marketed by BMD, for use in the new system. The company expects the new facility will put an end to current methods of testing that prove both traumatic for the patient and costly to healthcare providers in terms of time and money.
Quality of service and patient confidentiality are paramount. The system has built-in safeguards and will shut down if the pre-established protocols are breached.
The Triage Meter System not only provides a solution for cardiologists in the emergency room by dramatically reducing the time taken to make diagnoses but it also satisfies the stringent requirements of biologists who have complete control over the information.
This new approach to clinical testing not only offers major benefits to emergency services in France and other countries where BMD operates. It creates an opportunity for BMD to work with many laboratories and hospitals where there is a need and desire to benefit from this technological advance, said Daniel Pierron, Chairman and CEO of BMD.
The results of our collaboration
with BMD are extremely significant for cardiology units and emergency rooms, said Dr. Anne Gruson, laboratory Director at Arras Hospital.
Everyone taking part in the project has performed with the highest professionalism.
This and BMD's commitment in responding exactly to our requirements contributed greatly to the success of the project.

Comments
Post new comment